Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Asset Utilization Ratio (2020 - 2025)

Insight Molecular Diagnostics' Asset Utilization Ratio history spans 6 years, with the latest figure at 0.09 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 852.71% year-over-year to 0.09; the TTM value through Sep 2025 reached 0.09, up 852.71%, while the annual FY2024 figure was 0.03, 99.13% up from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.09 at Insight Molecular Diagnostics, up from 0.08 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.09 in Q3 2025 and bottomed at 0.01 in Q2 2023.
  • The 5-year median for Asset Utilization Ratio is 0.01 (2024), against an average of 0.02.
  • The largest annual shift saw Asset Utilization Ratio crashed 224.15% in 2023 before it skyrocketed 852.71% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then plummeted by 44.48% to 0.01 in 2022, then skyrocketed by 158.11% to 0.02 in 2023, then surged by 85.98% to 0.04 in 2024, then skyrocketed by 160.89% to 0.09 in 2025.
  • Per Business Quant, the three most recent readings for IMDX's Asset Utilization Ratio are 0.09 (Q3 2025), 0.08 (Q2 2025), and 0.08 (Q1 2025).